ZIMMER BIOMET HOLDINGS, INC. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax of $11.10 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax · last filed 2018-08-06
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2018-06-30 was $11.10M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2018-03-31 was -$6.70M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-12-31 was -$1.40M, a 104.78% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2017-09-30 was -$7.60M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2017 was -$21.00M, a 1600.00% decline from fiscal 2016.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2016 was $1.40M, a 78.13% decline from fiscal 2015.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2015 was $6.40M, a 39.13% increase from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2014 was $4.60M, a 84.77% decline from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 9 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2018-06-30 | $11.10M 10-Q · filed 2018-08-06 | $4.40M 10-Q · filed 2018-08-06 | $3.00M derived: sum of 3 quarters · filed 2018-08-06 | -$4.60M derived: sum of 4 quarters · filed 2018-08-06 | |
| 2018-03-31 | -$6.70M 10-Q · filed 2018-05-08 | -$8.10M derived: sum of 2 quarters · filed 2018-05-08 | -$15.70M derived: sum of 3 quarters · filed 2018-05-08 | -$17.40M derived: sum of 4 quarters · filed 2018-08-06 | |
| 2017-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$9.00M derived: sum of 2 quarters · filed 2018-02-27 | -$10.70M derived: sum of 3 quarters · filed 2018-08-06 | -$21.00M 10-K · filed 2018-02-27 | |
| 2017-09-30 | -$7.60M 10-Q · filed 2017-11-06 | -$9.30M derived: sum of 2 quarters · filed 2018-08-06 | -$19.60M 10-Q · filed 2017-11-06 | $9.70M derived: sum of 4 quarters · filed 2018-08-06 | |
| 2017-06-30 | -$1.70M 10-Q · filed 2018-08-06 | -$12.00M 10-Q · filed 2018-08-06 | $17.30M derived: sum of 3 quarters · filed 2018-08-06 | $10.90M derived: sum of 4 quarters · filed 2018-08-06 | |
| 2017-03-31 | -$10.30M 10-Q · filed 2018-05-08 | $19.00M derived: sum of 2 quarters · filed 2018-05-08 | $12.60M derived: sum of 3 quarters · filed 2018-05-08 | $3.50M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | $29.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $22.90M derived: sum of 2 quarters · filed 2018-02-27 | $13.80M derived: sum of 3 quarters · filed 2018-02-27 | $1.40M 10-K · filed 2018-02-27 | |
| 2016-09-30 | -$6.40M 10-Q · filed 2017-11-06 | -$15.50M derived: sum of 2 quarters · filed 2017-11-06 | -$27.90M 10-Q · filed 2017-11-06 | -$26.10M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$9.10M 10-Q · filed 2017-08-08 | -$21.50M 10-Q · filed 2017-08-08 | -$19.70M derived: sum of 3 quarters · filed 2018-02-27 | -$16.50M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$12.40M 10-Q · filed 2017-05-09 | -$10.60M derived: sum of 2 quarters · filed 2018-02-27 | -$7.40M derived: sum of 3 quarters · filed 2018-02-27 | -$5.30M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $5.00M derived: sum of 2 quarters · filed 2018-02-27 | $7.10M derived: sum of 3 quarters · filed 2018-02-27 | $6.40M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $3.20M 10-Q · filed 2015-11-09 | $5.30M derived: sum of 2 quarters · filed 2016-11-08 | $4.60M 10-Q · filed 2016-11-08 | $400.00K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $2.10M 10-Q · filed 2016-08-08 | $1.40M 10-Q · filed 2016-08-08 | -$2.80M derived: sum of 3 quarters · filed 2017-03-01 | $10.10M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | -$700.00K 10-Q · filed 2016-05-10 | -$4.90M derived: sum of 2 quarters · filed 2017-03-01 | $8.00M derived: sum of 3 quarters · filed 2017-03-01 | $4.70M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $8.70M derived: sum of 2 quarters · filed 2017-03-01 | $5.40M derived: sum of 3 quarters · filed 2017-03-01 | $4.60M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $12.90M 10-Q · filed 2015-11-09 | $9.60M derived: sum of 2 quarters · filed 2015-11-09 | $8.80M 10-Q · filed 2015-11-09 | $17.20M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$3.30M 10-Q · filed 2015-08-10 | -$4.10M 10-Q · filed 2015-08-10 | $4.30M derived: sum of 3 quarters · filed 2016-02-29 | $1.20M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$800.00K 10-Q · filed 2015-05-07 | $7.60M derived: sum of 2 quarters · filed 2016-02-29 | $4.50M derived: sum of 3 quarters · filed 2016-02-29 | $13.80M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.30M derived: sum of 2 quarters · filed 2016-02-29 | $14.60M derived: sum of 3 quarters · filed 2016-02-29 | $30.20M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$3.10M 10-Q · filed 2014-11-05 | $6.20M derived: sum of 2 quarters · filed 2014-11-05 | $21.80M 10-Q · filed 2014-11-05 | $30.10M derived: sum of 4 quarters · filed 2015-02-23 | |
| 2013-06-30 | $9.30M 10-Q · filed 2014-08-07 | $24.90M 10-Q · filed 2014-08-07 | $33.20M derived: sum of 3 quarters · filed 2015-02-23 | $22.70M derived: sum of 4 quarters · filed 2015-02-23 | |
| 2013-03-31 | $15.60M 10-Q · filed 2014-05-06 | $23.90M derived: sum of 2 quarters · filed 2015-02-23 | $13.40M derived: sum of 3 quarters · filed 2015-02-23 | $16.00M derived: sum of 4 quarters · filed 2015-02-23 | |
| 2012-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | -$2.20M derived: sum of 2 quarters · filed 2015-02-23 | $400.00K derived: sum of 3 quarters · filed 2015-02-23 | $4.30M 10-K · filed 2015-02-23 | |
| 2012-09-30 | -$10.50M 10-Q · filed 2013-11-12 | -$7.90M derived: sum of 2 quarters · filed 2013-11-12 | -$4.00M 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $2.60M 10-Q · filed 2013-08-07 | $6.50M 10-Q · filed 2013-08-07 | |||
| 2012-03-31 | $3.90M 10-Q · filed 2013-05-08 | ||||
| 2011-12-31 | -$4.30M 10-K · filed 2014-02-28 | ||||
| 2010-12-31 | -$10.10M 10-K · filed 2013-02-27 | $10.10M 10-K · filed 2011-02-25 | |||
| 2009-12-31 | -$8.90M 10-K · filed 2012-02-27 | $8.90M 10-K · filed 2010-02-25 | |||
| 2008-12-31 | $700.00K 10-K · filed 2011-02-25 | ||||
| 2007-12-31 | $11.50M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |